ArticleProceedings of the National Academy of Sciences of the United States of America2020
Haplotype networks of SARS-CoV-2 infections in the
Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 84 citations in OpenAlex.
- Local genomic epidemiology investigations of SARS-CoV-2 during the early pandemic response: A global systematic review.Epidemiology and infection · 2026Pooled it
- Systematic Review on Outbreaks of SARS-CoV-2 on Cruise, Navy and Cargo Ships.International journal of environmental research and public health · 2021Pooled it
- HaploThread: a scalable desktop tool for efficient haplotype network inference and interactive visualization.Molecular biology and evolution · 2026Article
- Emerging Multi-Source Transmission of SFTS Virus on a Remote Japanese Island: A One-Health Perspective.International journal of molecular sciences · 2026Article
- Estimating epidemic dynamics with genomic and time series data.Journal of the Royal Society, Interface · 2025Article
- Epidemic-induced local awareness behavior inferred from surveys and genetic sequence data.Nature communications · 2025Article
- Methodology of Epidemic Risk Analysis in the Naval Military.International journal of environmental research and public health · 2025Review
- Recently reported SARS-CoV-2 genomes suggested to be intermediate between the two early main lineages are instead likely derived.Virus evolution · 2025Article
- Haplotypic Distribution of SARS-CoV-2 Variants in Cases of Intradomiciliary Infection in the State of Rondônia, Western Amazon.Bioinformatics and biology insights · 2024Article
- Evolutionary trajectory of diverse SARS-CoV-2 variants at the beginning of COVID-19 outbreak.Virus evolution · 2024Article
- Reconstructing early transmission networks of SARS-CoV-2 using a genomic mutation model.Zoological research · 2023Article
- COVID-19 outbreaks among crew on commercial ships at the Port of Rotterdam, the Netherlands, 2020 to 2021.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023Article
- Extensive Spread of SARS-CoV-2 Delta Variant among Vaccinated Persons during 7-Day River Cruise, the Netherlands.Emerging infectious diseases · 2023Article
- Temporal dynamics of SARS-CoV-2 genome mutations that occurredBiosafety and health · 2023Article
- Transmission of SARS-CoV-2 Associated with Cruise Ship Travel: A Systematic Review.Tropical medicine and infectious disease · 2022Review
- Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic.Nature reviews. Genetics · 2022Review
- The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2.Science (New York, N.Y.) · 2022Article
- A database for retrieving information on SARS-CoV-2 S protein mutations based on correlation network analysis.BMC genomic data · 2022Article
- An interactive viral genome evolution network analysis system enabling rapid large-scale molecular tracing of SARS-CoV-2.Science bulletin · 2022Article
- Pro108Ser mutation of SARS-CoV-2 3CLScientific reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.